ClinicalTrials.Veeva

Menu

Efficacy of the "Milk Ladder" Intervention in the Development of Tolerance and the Recognition of B Cell Epitopes in Babies Who Are Allergic to Cow's Milk Proteins

S

San Carlos Clinical Hospital

Status

Unknown

Conditions

IgE-mediated Milk Allergy

Treatments

Other: Milk

Study type

Interventional

Funder types

Other

Identifiers

NCT03466931
Milk Ladder

Details and patient eligibility

About

Food allergies have become a relevant health problem in westernized societies, particularly, with children. Cow's milk (CM), along with hen's eggs, are the most common foods eliciting allergic reactions in children under 4 years of age. The main objective of this intervention study is to evaluate the safety and efficacy of the intervention known as "The Milk Ladder" in the development of tolerance by children with CM allergies. This will be compared to an historical cohort (CoALE), which investigated the natural history of this allergy. Additionally, the ability of informative epitopes will be evaluated for their potential to predict tolerance and their correlation against clinical variables.

The "Milk Ladder" will be evaluated within a prospective cohort of CM allergic children. This intervention is enacted through the introduction of meals cooked with progressively increasing amounts of cow's milk into the participant's diet. The primary outcome will be the development of tolerance which will be evaluated through a double-blind placebo-controlled food challenge. IgE and IgG4 epitopes will be described using a peptide microarray immunoassay. Quality of life will be determined by administering the FAQLQ-PF disease-specific questionnaire. Finally, within a subgroup of study participants, the ability of different peptides to activate basophils will be analyzed, and CM T cell epitopes will be studied by means of T-cell proliferation and cytokine production assays.

Enrollment

114 estimated patients

Sex

All

Ages

1 to 12 months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Babies of both sexes.

  • Age < 12 months.

  • Clinical history of immediate reaction (<2 hours) after the intake of baby's formula and/or foods containing cow's milk.

  • Sensitization to cow's milk proteins demonstrated by:

    • sIgE to cow's milk, alpha-Lactoabumin, beta-Lactoglobulin and/or Casein >0.1KU/l (ImmunoCAP®, ThemoFisher) and/or
    • Skin prick test to cow's milk, alpha-Lactoabumin, beta-Lactoglobulin and/or Casein ≥3mm
  • If the reaction to milk occurred over 3 months before the recruitment, it will be mandatory to confirm reactivity to milk with an oral food test.

  • Parents / legal representatives of the participant voluntary accept to participate.

Exclusion criteria

  • Delayed reactions (> 2 h) after milk intake.
  • Contact urticaria to milk if ingestion is well tolerated.
  • Previous participation in oral tolerance induction/desensitization protocols.
  • Treatment with any medication that might interfere the evaluation of the primary outcome or any study procedure.
  • Any disease or condition which presents a contraindication to perform an oral challenge, either open or double-blind or any other study procedure.
  • Social circumstances that might interfere with protocol adherence.
  • Egg and/or wheat allergy (this exclusion criterion shall be verified before the beginning of the intervention).

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

114 participants in 2 patient groups

Dietary intervention
Experimental group
Description:
Meals containing Milk and Milk
Treatment:
Other: Milk
Historical cohort
No Intervention group
Description:
Standard care

Trial contacts and locations

1

Loading...

Central trial contact

Inmaculada Cerecedo, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems